The new hires include: Amy Wesa, PhD, as senior vice president of preclinical and translational research; Alexandra (Xana) Capela, PhD, as senior vice president of regulatory and investigational new drug application strategy; and Michael Kuo as senior vice president of manufacturing.

In addition, Vita has appointed Brown Advisory Chief Financial Officer and Chief Operating Officer David Churchill to its board of directors.